Evozyne raises $81m to leverage AI for drug discovery

Evozyne raises $81m to leverage AI for drug discovery

Source: 
Biopharma Reporter
snippet: 

Evozyne has announced the closing of an $81 million series B investment round that will fund the biotech's generative AI-powered drug discovery platform and product development.